[China Pharmas, Announces Approval for NYSE Amex Listing HAIKOU CITY, China, September 28, 2009 - China Pharmas, ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and marketsecialty pharmaceutical products in China, today announced that it has received approval to list its securities on NYSE Amex.]
[FORM 8-K CURRENT REPORT October 1, 2009 China Pharmas, ------------------------------ Delaware (State or other jurisdiction oforporation) 000-29532 73-1564807 (IRS Employer Identification Number) 2nd Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 86-898-66811730fe Harbor Statement under the Private Securities Litigation Reform Act of 1995 Item 8.01. Other Events.]
[FORM 8-K CURRENT REPORT October 1, 2009 China Pharmas, ------------------------------ Delaware (State or other jurisdiction oforporation) 000-29532 73-1564807 (IRS Employer Identification Number) 2nd Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 86-898-66811730fe Harbor Statement under the Private Securities Litigation Reform Act of 1995 Item 8.01. Other Events.]
[FORM 8-K CURRENT REPORT August 28, 2009 China Pharma Holdings, Inc ------------------------------ Delaware (State or other jurisdiction of incorporation) 000-29532 73-1564807 (IRS Employer Identification Number)]
[Explanatory Note Company Common Stock Exchange Act This Registration Statement on Form 8-A is being filed by China Pharma Holdings, Inc., a Delaware corporation (the “ Item 1. Description of the Company’s Securities to be Registered Commission 1]
[Explanatory Note Company Common Stock Exchange Act This Registration Statement on Form 8-A is being filed by China Pharma Holdings, Inc., a Delaware corporation (the “ Item 1. Description of the Company’s Securities to be Registered Commission 1]
